FindCure Biosciences
Latest round
- Series B
Last raised
- Feb 2026
Total raised
- $14M
Investors
- 6
About FindCure Biosciences
, trading as FindCure Biosciences, is a biotechnology company whose primary business is the development of new anti-cancer drugs. It has established an R&D laboratory in Zhongshan. Some enterprises, such as BioDuro, Pharmaron, and KYinno, have cooperated with the company. In August 2020, the company set up a subsidiary in Shenzhen. FindCure Biosciences focuses on drug discovery and development targeting signaling pathways and immunotherapy, including small molecule targeted drugs, large molecule proteins and antibody drugs with independent intellectual property rights. The company's products, selective Axl inhibitor FC084 and type II met inhibitor FC413, have both entered the phase I clinical stage, and PI3K? inhibitor FC919 is undergoing IND filing. The products can be used in curing stomach and lung cancer. The company's revenue is generated by providing cancer drug development service. The series B funds will be mainly used for the construction of the nuclear drug platform and the advancement of clinical trials, helping the company enter a new stage of development.
Who invested in FindCure Biosciences
6 investors across 2 rounds
See all investors in FindCure Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about FindCure Biosciences
Who invested in FindCure Biosciences?
FindCure Biosciences has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has FindCure Biosciences raised?
FindCure Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did FindCure Biosciences last raise money?
FindCure Biosciences's most recent round on record is a Series B, in Feb 2026.
What does FindCure Biosciences do?
, trading as FindCure Biosciences, is a biotechnology company whose primary business is the development of new anti-cancer drugs.
Where is FindCure Biosciences headquartered?
FindCure Biosciences is headquartered in Zhongshan, China.
Which VCs invest in companies like FindCure Biosciences?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at FindCure Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like FindCure Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.